The obesity drugs waiting to hit the market
1 year, 4 months ago

The obesity drugs waiting to hit the market

The Hindu  

Novo Nordisk said a large study had shown its highly effective obesity drug Wegovy also had a clear cardiovascular benefit, boosting the Danish drugmaker’s hopes of moving beyond Wegovy’s image as a lifestyle drug. The following is a list of companies targeting the next big blockbuster opportunity: Novo Nordisk said a large study had shown its highly effective obesity drug, Wegovy, also had a clear cardiovascular benefit In June, the drugmaker reported late-stage trial data from a high-dose oral version of its drug, semaglutide, helping overweight or obese adults lose 15% of their body weight, in line with recent results for other experimental pills. It said a mid-stage trial of its next-generation obesity drug candidate, a once-weekly injection of retatrutide, showed it led to a weight loss of up to 24.2% after 48 weeks. Amgen’s experimental obesity drug, AMG133, showed a mean weight loss of 14.5% after 12 weeks of treatment at the highest monthly dose.

Trial Obesity Weight Drug Wegovy  market  wegovy  treatment  trial  drugs  midstage  obesity  loss  study  hit  showed  drug  weight  waiting

History of this topic

Opinion: Weight-loss drugs are great, but real food still matters
5 days, 2 hours ago

Opinion: Weight-loss drugs are great, but real food still matters

LA Times  

Salty and fatty manufactured foods, along with sweet ones, have been engineered to encourage snacking and excessive eating. Companies have reshaped the food system to produce ultraprocessed, hyperpalatable and highly profitable foods, leading people to snack more, eat larger portions and prepare fewer meals themselves. Just as health experts urge us to reduce our intake of salt, fat and sugar, …

Consultations for obesity drug prescriptions are way up over 2023, survey finds
1 week, 5 days ago

Consultations for obesity drug prescriptions are way up over 2023, survey finds

NPR  

Consultations for obesity drug prescriptions are way up over 2023, survey finds Appointments with health professionals for obesity drug consultations are way up, according to data from Zocdoc, a provider of scheduling services. SYDNEY LUPKIN, BYLINE: Doctor Sarah Nosal, a family physician in the South Bronx, New York, says a lot more of her patients have come in asking about …

Eli Lilly new trial is all about the battle to be best weight-loss drug zepbound and wegovy
2 weeks, 5 days ago

Eli Lilly new trial is all about the battle to be best weight-loss drug zepbound and wegovy

India Today  

In a study trial, pharmaceutical giant Eli Lilly's weight-loss drug Zepbound showed better results than another pharmaceutical company, Novo Nordisk's weight-loss drug Wegovy. The trial, called SURMOUNT-5, compared Zepbound to Wegovy, which is a mono GLP-1 receptor agonist in adults living with obesity without diabetes. The results showed Zepbound delivering a remarkable 47% greater relative weight loss compared to Wegovy, …

Weight-loss meds go head-to-head in new study. One was significantly more effective, drugmaker says
2 weeks, 5 days ago

Weight-loss meds go head-to-head in new study. One was significantly more effective, drugmaker says

The Independent  

Sign up to our free Living Well email for advice on living a happier, healthier and longer life Live your life healthier and happier with our free weekly Living Well newsletter Live your life healthier and happier with our free weekly Living Well newsletter SIGN UP I would like to be emailed about offers, events and updates from The Independent. …

Zepbound tops Wegovy for weight loss in Eli Lilly study
2 weeks, 5 days ago

Zepbound tops Wegovy for weight loss in Eli Lilly study

Associated Press  

Share Share Copy Link copied Email Facebook X Reddit LinkedIn Pinterest Flipboard Print Shares of Eli Lilly climbed Wednesday after the drugmaker detailed a study showing that its blockbuster weight-loss drug Zepbound helped patients shed more pounds than Wegovy from rival Novo Nordisk. Lilly said patients taking Zepbound lost about 20% of their weight on average compared to nearly 14% …

Eli Lilly’s Zepbound beats Novo Nordisk’s Wegovy in first head-to-head study
2 weeks, 5 days ago

Eli Lilly’s Zepbound beats Novo Nordisk’s Wegovy in first head-to-head study

Live Mint  

In the first head-to-head test, Eli Lilly’s Zepbound obesity drug helped people lose significantly more weight than its main competitor, Novo Nordisk’s Wegovy. The details People taking Zepbound lost 20.2% of their body weight on average after 72 weeks of treatment in the Lilly- That translated into an average 50-pound loss for people who took Zepbound, while Wegovy users lost …

Cheap Ozempic? Millions of obese Americans wait on Trump’s decision
3 weeks, 5 days ago

Cheap Ozempic? Millions of obese Americans wait on Trump’s decision

The Independent  

The latest headlines from our reporters across the US sent straight to your inbox each weekday Your briefing on the latest headlines from across the US Your briefing on the latest headlines from across the US SIGN UP I would like to be emailed about offers, events and updates from The Independent. The rule, unveiled on Tuesday by the Health …

Cheap Ozempic? How millions of Americans with obesity may get access to costly weight-loss drugs
Trending News
3 weeks, 6 days ago

Cheap Ozempic? How millions of Americans with obesity may get access to costly weight-loss drugs

Associated Press  

WASHINGTON — Millions of obese Americans would get access to popular weekly injectables that would help them shed pounds quickly if a $ 35 billion proposal from the Biden administration is blessed by President-elect Donald Trump. The rule, unveiled Tuesday by the Health and Human Services Department, would require Medicare and Medicaid to cover weight-loss drugs like Wegovy or Zepbound …

What happens when Ozempic and Wegovy don’t work?
4 weeks, 1 day ago

What happens when Ozempic and Wegovy don’t work?

The Independent  

Sign up to our free Living Well email for advice on living a happier, healthier and longer life Live your life healthier and happier with our free weekly Living Well newsletter Live your life healthier and happier with our free weekly Living Well newsletter SIGN UP I would like to be emailed about offers, events and updates from The Independent. …

Scientific breakthrough to prevent negative side effects of weight loss drugs like Ozempic
1 month ago

Scientific breakthrough to prevent negative side effects of weight loss drugs like Ozempic

The Independent  

Sign up to our free Living Well email for advice on living a happier, healthier and longer life Live your life healthier and happier with our free weekly Living Well newsletter Live your life healthier and happier with our free weekly Living Well newsletter SIGN UP I would like to be emailed about offers, events and updates from The Independent. …

Weight-loss drug Wegovy launched in China
1 month ago

Weight-loss drug Wegovy launched in China

CNN  

Novo Nordisk said Monday it has launched its popular obesity drug Wegovy in China, the world’s second-largest pharmaceuticals market where it estimates more than 180 million people live with obesity. Novo gained approval for Wegovy in China in June and will initially target Chinese patients willing to pay out-of-pocket for the weekly injectable drug. Strong sales there and in the …

Wegovy/Mounjaro: The UK thinks weight loss drugs could ease unemployment. Experts say that’s a fantasy
Trending News
1 month, 1 week ago

Wegovy/Mounjaro: The UK thinks weight loss drugs could ease unemployment. Experts say that’s a fantasy

CNN  

London CNN — Weight loss drugs such as Wegovy and Ozempic have been hailed worldwide as revolutionary for medicine. British Prime Minister Keir Starmer has said that his government needs to “think differently” about how to reduce pressure on the country’s national health care system, overburdened amid staffing shortages and funding pressures. Tom Little/Reuters The government trial studying links between …

Obesity Pill Data Portend Competition, Hitting Drugmaker Shares
1 month, 2 weeks ago

Obesity Pill Data Portend Competition, Hitting Drugmaker Shares

Live Mint  

-- Obesity pill data released by Viking Therapeutics Inc. and AstraZeneca Plc at a big conference foreshadowed an increasingly competitive landscape for weight-loss therapies, sending down shares of drugmakers in the field. Effectiveness and safety data from Viking’s study, released Sunday at an industry conference, show that an obesity pill could be a reality soon: People who took 100-milligram doses …

Big Pharma’s obesity bonanza faces new tests
1 month, 2 weeks ago

Big Pharma’s obesity bonanza faces new tests

Live Mint  

In terms of recent stock-market frenzies, the Ozempic trade nearly tops the list, second only to speculation that artificial intelligence will soon be writing this column. Powerful weight-loss drugs like Wegovy and Zepbound have driven nearly $1 trillion in market-capitalization gains, with most of those gains flowing to Eli Lilly and Novo Nordisk, the dominant players in the obesity-drug market. …

Ozempic, Wegovy considered ‘available’ after more than 2 years in shortage
1 month, 3 weeks ago

Ozempic, Wegovy considered ‘available’ after more than 2 years in shortage

The Independent  

Sign up to our free Living Well email for advice on living a happier, healthier and longer life Live your life healthier and happier with our free weekly Living Well newsletter Live your life healthier and happier with our free weekly Living Well newsletter SIGN UP I would like to be emailed about offers, events and updates from The Independent. …

The US has passed peak obesity, a new survey suggests. Is it the Ozempic effect?
2 months, 2 weeks ago

The US has passed peak obesity, a new survey suggests. Is it the Ozempic effect?

The Independent  

Sign up for our free Health Check email to receive exclusive analysis on the week in health Get our free Health Check email Please enter a valid email address Please enter a valid email address SIGN UP I would like to be emailed about offers, events and updates from The Independent. Please try again later {{ /verifyErrors }} The United …

Wegovy weight loss: The science and the hype of supplements
2 months, 2 weeks ago

Wegovy weight loss: The science and the hype of supplements

The Hindu  

Published : Oct 04, 2024 18:39 IST - 5 MINS READ It was sometime during the COVID-19 pandemic when Wegovy and Ozempic hit mainstream awareness. When used as a weight loss medication, Wegovy is only recommended “as an adjunct to diet and exercise to reduce weight in patients who are very obese,” Ward told DW. But the side effects mean …

What It’s Really Like to Take Ozempic
2 months, 3 weeks ago

What It’s Really Like to Take Ozempic

Slate  

GLP-1 drugs like Ozempic, WeGovy, Mounjaro and others revolutionized weight loss and chronic weight management. Over the course of a year, Johann dived into the research and history behind GLP-1 drugs and how they became the latest and most effective way to lose weight. His latest book Magic Pill: The Extraordinary Benefits and Disturbing Risks of the New Weight-Loss Drugs …

Ozempic and Wegovy can supercharge weight loss and even defy ageing – but can they save the NHS?
3 months, 3 weeks ago

Ozempic and Wegovy can supercharge weight loss and even defy ageing – but can they save the NHS?

The Independent  

Sign up for our free Health Check email to receive exclusive analysis on the week in health Get our free Health Check email Please enter a valid email address Please enter a valid email address SIGN UP I would like to be emailed about offers, events and updates from The Independent. Another piece of research from the same trial suggested …

Wegovy: Ozempic sister drug to be sold in Australia within days
4 months, 3 weeks ago

Wegovy: Ozempic sister drug to be sold in Australia within days

Daily Mail  

A drug that mimics popular weight loss medicine Ozempic will be available in Australian pharmacies within days. Like Ozempic, the drug is administered through a once-weekly pen, however it contains a higher amount of the active ingredient and is used to manage chronic weight conditions, whereas Ozempic is only approved to manage type 2 diabetes. In May the Australian government …

The science of tirzepatide, touted as a game-changing weight loss drug
4 months, 4 weeks ago

The science of tirzepatide, touted as a game-changing weight loss drug

Hindustan Times  

Indians will soon have access to a new drug that targets obesity and diabetes, two diseases, which are widely prevalent among our population. They stimulate the release of insulin, and help increase insulin sensitivity in adipose and skeletal tissue,” said RNV Krishna Deepak, a computational structural biologist at Azim Premji University, Bengaluru. “Tirzepatide has received marketing authorisation for type-2 diabetes …

India one step closer to approving weight-loss drug tirzepatide: What is it? How does it work?
5 months, 1 week ago

India one step closer to approving weight-loss drug tirzepatide: What is it? How does it work?

Firstpost  

Eli Lilly, the pharmaceutical company, has received the first approval for the sale of its blockbuster drug Tirzepatide in India. Here’s what we know about this ‘game-changing’ medication A box of Mounjaro, a tirzepatide injection drug used for treating type 2 diabetes made by Lilly is seen at Rock Canyon Pharmacy in Provo, Utah. Last week, the apex drug regulator’s, …

Study links popular weight loss drugs to rare blinding eye condition
5 months, 2 weeks ago

Study links popular weight loss drugs to rare blinding eye condition

Hindustan Times  

Popular weight loss drugs have been linked to an uncommon eye-blinding condition, according to a new study. Study links popular weight loss drugs to rare blinding eye condition Patients with diabetes or obesity are commonly prescribed weight loss drugs, such as Ozempic or Wegovy, containing the protein semaglutide, which helps manage blood sugar by promoting production of insulin. A team …

Wegovy weight-loss drug OK'd in China
5 months, 4 weeks ago

Wegovy weight-loss drug OK'd in China

China Daily  

FILE PHOTO: A view shows the logo of Novo Nordisk at the company's office in Bagsvaerd, on the outskirts of Copenhagen, Denmark, March 8, 2024. Danish drugmaker Novo Nordisk said Tuesday that its injectable weight-loss drug Wegovy has been approved in China, where the proportion of overweight and obese adults reached almost 51 percent of the country's 1.4 billion people …

Wegovy weight-loss drug OK'd in China
5 months, 4 weeks ago

Wegovy weight-loss drug OK'd in China

China Daily  

By AI HEPING in New York | chinadaily.com.cn | Updated: 2024-06-26 14:54 FILE PHOTO: A view shows the logo of Novo Nordisk at the company's office in Bagsvaerd, on the outskirts of Copenhagen, Denmark, March 8, 2024. Danish drugmaker Novo Nordisk said Tuesday that its injectable weight-loss drug Wegovy has been approved in China, where the proportion of overweight and …

New weight loss drugs are on the way — and the health benefits are even more promising
5 months, 4 weeks ago

New weight loss drugs are on the way — and the health benefits are even more promising

The Independent  

Sign up for our free Health Check email to receive exclusive analysis on the week in health Get our free Health Check email Get our free Health Check email SIGN UP I would like to be emailed about offers, events and updates from The Independent. Read our privacy policy Pharmaceutical companies are racing to develop new weight loss drugs following …

There’s yet another amazing use for drugs like Ozempic, study finds
6 months, 4 weeks ago

There’s yet another amazing use for drugs like Ozempic, study finds

The Independent  

The latest headlines from our reporters across the US sent straight to your inbox each weekday Your briefing on the latest headlines from across the US Please enter a valid email address Please enter a valid email address SIGN UP I would like to be emailed about offers, events and updates from The Independent. Please try again later {{ /verifyErrors …

Doctors declare Ozempic overrated as first long-term trial shows patients keep just 10% of their bodyweight off after four YEARS on drug
7 months, 1 week ago

Doctors declare Ozempic overrated as first long-term trial shows patients keep just 10% of their bodyweight off after four YEARS on drug

Daily Mail  

They've been billed as 'miracle' drugs and are credited with spurring incredible weight-loss transformations in Hollywood. Wegovy, developed by the Danish Novo Nordisk, is a weekly injectable drug that leads to 10 percent weight loss on average. The new study was from Ozempic manufacturer Novo Nordisk and looked at 17,604 adults across 40 countries taking Wegovy, which is the same …

Ozempic: What are weight loss injections and how can I get them?
7 months, 1 week ago

Ozempic: What are weight loss injections and how can I get them?

The Independent  

Sign up for our free Health Check email to receive exclusive analysis on the week in health Get our free Health Check email Please enter a valid email address Please enter a valid email address SIGN UP I would like to be emailed about offers, events and updates from The Independent. Ozempic can only be prescribed for patients with type …

Gradual weaning off anti-obesity jabs could help avoid weight gain – study
7 months, 1 week ago

Gradual weaning off anti-obesity jabs could help avoid weight gain – study

The Independent  

For free real time breaking news alerts sent straight to your inbox sign up to our breaking news emails Sign up to our free breaking news emails Please enter a valid email address Please enter a valid email address SIGN UP I would like to be emailed about offers, events and updates from The Independent. “Using lower doses of semaglutide …

‘Miracle’ weight-loss drugs could have reduced health disparities. Instead they got worse
8 months, 1 week ago

‘Miracle’ weight-loss drugs could have reduced health disparities. Instead they got worse

LA Times  

Wegovy is part of a new generation of weight-loss medications that made some doctors optimistic about reversing longstanding racial and ethnic disparities in obesity. “These patients have a higher burden of disease, and they’re less likely to get the medicine that can save their lives,” said Dr. Lauren Eberly, a cardiologist and health services researcher at the University of Pennsylvania. …

How do Ozempic and other weight-loss drugs work? | In Focus podcast
8 months, 3 weeks ago

How do Ozempic and other weight-loss drugs work? | In Focus podcast

The Hindu  

Weight-loss drugs including Ozempic, Wegovy and Mounjaro have been making headlines across the world for weight loss; celebrities including Oprah Winfrey and Elon Musk have spoken about using them to quickly and drastically lose weight. First approved for diabetes treatment, these drugs, which consist of semaglutide – are available in tablet and injectable form. While the tablet form was approved …

Medicare can pay for obesity drugs like Wegovy in certain heart patients
9 months ago

Medicare can pay for obesity drugs like Wegovy in certain heart patients

Associated Press  

Medicare can pay for the popular weight-loss drug Wegovy — as long as the patients using it also have heart disease and need to reduce the risk of future heart attacks, strokes and other serious problems, federal officials said Thursday. Part D plans could begin covering the drug “some time this year,” said Tricia Neuman, a Medicare policy specialist at …

Medicare can pay for obesity drugs like Wegovy in certain heart patients
9 months ago

Medicare can pay for obesity drugs like Wegovy in certain heart patients

The Independent  

For free real time breaking news alerts sent straight to your inbox sign up to our breaking news emails Sign up to our free breaking news emails Sign up to our free breaking news emails SIGN UP I would like to be emailed about offers, events and updates from The Independent. Read our privacy policy Medicare can pay for the …

Oprah Winfrey on why she left WeightWatchers after admitting to weight loss drug use
9 months, 1 week ago

Oprah Winfrey on why she left WeightWatchers after admitting to weight loss drug use

The Independent  

Sign up to our free Living Well email for advice on living a happier, healthier and longer life Live your life healthier and happier with our free weekly Living Well newsletter Live your life healthier and happier with our free weekly Living Well newsletter SIGN UP I would like to be emailed about offers, events and updates from The Independent. …

Obesity drug Wegovy is approved to cut heart attack and stroke risk in overweight patients
9 months, 2 weeks ago

Obesity drug Wegovy is approved to cut heart attack and stroke risk in overweight patients

Associated Press  

The popular weight-loss drug Wegovy, which has helped millions of Americans shed pounds, can now be used to reduce the risk of stroke, heart attacks and other serious cardiovascular problems in patients who are overweight or who have obesity, federal regulators said Friday. The decision was based on the results of a study that found that Wegovy cut the risk …

Can weight loss drugs like Ozempic, Wegovy treat other diseases?
11 months, 3 weeks ago

Can weight loss drugs like Ozempic, Wegovy treat other diseases?

Live Mint  

Researchers are studying prominent weight-loss medicines like Ozempic and Wegovy to find their utility in the treatment of kidney disease, heart failure, neurological disorders, and other ailments. After creating buzz in the weight-loss segment, the medicine may also be useful in reducing the risk of heart stroke, and delaying the progression of kidney disease in diabetes patients, suggests new data, …

Novo Nordisk pays $25.8 million to promote its obesity drug
1 year ago

Novo Nordisk pays $25.8 million to promote its obesity drug

Live Mint  

During his address, Dr. Lee Kaplan urged fellow doctors to use their prescription pads to fight the obesity crisis, according to a report by Reuters on December 1. Dr. Kaplan, a leading U.S. weight-loss specialist, recommended turning to new weight-loss medicines like Novo Nordisk's Wegovy to reduce obesity. “We are going to have to use these medications,” he said at …

Pfizer struggles to catch up to Ozempic, Wegovy with weight-loss pill
1 year ago

Pfizer struggles to catch up to Ozempic, Wegovy with weight-loss pill

LA Times  

On Friday, Pfizer announced that it’s dropping development of an experimental weight-loss pill after patients experienced uncomfortable side effects in clinical trials. Rybelsus, Novo’s pill version of the diabetes shot Ozempic that’s often used for weight loss, is available at $936 for a one-month supply. Pills like Pfizer’s that are small molecule drugs may generally pose a higher risk for …

Pfizer nixes more study of twice-daily obesity pill treatment that made many patients nauseous
1 year ago

Pfizer nixes more study of twice-daily obesity pill treatment that made many patients nauseous

Associated Press  

Pfizer shares sank Friday when the drugmaker said it would abandon a twice-daily obesity treatment after more than half the patients in a clinical trial stopped taking it. Pfizer said it saw patient discontinuation rates topping 50% across all doses in a mid-stage study of twice-daily danuglipron. By comparison, obese patients without diabetes lost about 18% of their weight compared …

Big Pharma scrambles to feed demand for weight-loss treatments amid rising US obesity rates
1 year, 1 month ago

Big Pharma scrambles to feed demand for weight-loss treatments amid rising US obesity rates

Associated Press  

NEW YORK — Obesity rates in the U.S. have been rising steadily for well over a decade and some of the world’s biggest drug developers are tapping into the growing treatment market. It notably priced the drug at roughly a 20% discount to Novo Nordisk’s Wegovy as the companies try to entice more employers to include weight-loss drugs in their …

Obesity drug Wegovy cut risk of serious heart problems by 20%, study finds
1 year, 1 month ago

Obesity drug Wegovy cut risk of serious heart problems by 20%, study finds

Associated Press  

The popular weight-loss drug Wegovy reduced the risk of serious heart problems by 20% in a large, international study that experts say could change the way doctors treat certain heart patients. “It moves from a kind of therapy that reduces body weight to a therapy that reduces cardiovascular events,” said Dr. Michael Lincoff, the study’s lead author and a heart …

AstraZeneca joins obesity drug craze as it signs £1.6bn deal with Chinese medical group
1 year, 1 month ago

AstraZeneca joins obesity drug craze as it signs £1.6bn deal with Chinese medical group

Daily Mail  

AstraZeneca has entered the race to develop a weight-loss drug after striking a £1.6billion deal with a Chinese medical group. China deal: AstraZeneca boss Pascal Soriot said that the move into weight loss drugs follows 'enormous need around the world' Details emerged just hours after it was revealed that AstraZeneca is facing a multi-million-pound legal battle over claims the efficacy …

A new version of the diabetes drug Mounjaro can be used for weight loss, FDA says
1 year, 1 month ago

A new version of the diabetes drug Mounjaro can be used for weight loss, FDA says

Associated Press  

A new version of the popular diabetes treatment Mounjaro can be sold as a weight-loss drug, U.S. regulators announced Wednesday. Zepbound is the latest diabetes drug approved for chronic weight management, joining Novo Nordisk’s Wegovy, a high-dose version of its diabetes treatment Ozempic. “This would be the most highly efficacious drug ever approved for the treatment of obesity,” said Dr. …

Oprah Winfrey admits she refused to take Ozempic and Wegovy for weight loss: ‘That’s the easy way out’
1 year, 3 months ago

Oprah Winfrey admits she refused to take Ozempic and Wegovy for weight loss: ‘That’s the easy way out’

The Independent  

Stay ahead of the curve with our weekly guide to the latest trends, fashion, relationships and more Stay ahead of the curve with our weekly guide to the latest trends, fashion, relationships and more Stay ahead of the curve with our weekly guide to the latest trends, fashion, relationships and more SIGN UP I would like to be emailed about …

How does Wegovy work? The ‘game changing’ weight loss drug beloved by Hollywood
1 year, 3 months ago

How does Wegovy work? The ‘game changing’ weight loss drug beloved by Hollywood

The Independent  

Sign up to our free Living Well email for advice on living a happier, healthier and longer life Live your life healthier and happier with our free weekly Living Well newsletter Please enter a valid email address Please enter a valid email address SIGN UP I would like to be emailed about offers, events and updates from The Independent. Please …

Ozempic in the spotlight is just the latest in the long, strange history of weight-loss drugs
1 year, 3 months ago

Ozempic in the spotlight is just the latest in the long, strange history of weight-loss drugs

Salon  

This article was originally published on The Conversation. That's been the holy grail of weight-loss ever since 19th century English undertaker and weight-loss celebrity William Banting's 1863 Letter on Corpulence spruiked his "miraculous" method of slimming down. Ozempic is a recent arrival Ozempic and its sister drug Wegovy, both manufactured by Novo Nordisk, are the latest offerings in a long …

Obesity drug Wegovy reduces heart attacks and strokes risk by 20%, shows study
1 year, 4 months ago

Obesity drug Wegovy reduces heart attacks and strokes risk by 20%, shows study

Hindustan Times  

Novo Nordisk A/S shares surged to a record after the Danish company’s blockbuster obesity medicine Wegovy reduced the risk of heart attacks and strokes in a highly anticipated study, giving it another potential boost. Obesity drug Wegovy reduces heart attacks and strokes risk by 20%, shows study Patients with obesity or overweight and with a history of cardiovascular issues taking …

Ozempic, weight-loss drugs probed over reports of suicidal thoughts
1 year, 5 months ago

Ozempic, weight-loss drugs probed over reports of suicidal thoughts

LA Times  

Novo Nordisk A/S’s weight-loss drugs, including the injectable drug Ozempic, are being investigated by regulators after they received reports of patients experiencing suicidal thoughts. Novo Nordisk A/S’s weight-loss medications are under investigation by the European Union’s drugs regulator after a small number of reports of suicidal risks were referred to the watchdog. The European Medicines Agency is looking at adverse …

Discover Related